Company Overview
Snapshot
Founded in August 2016 by Adam Singolda, Allon Bloch, and Ran Shaul, K Health operates with 201–500 employees. The company has raised a total of $383.8 million across 9 funding rounds from 24 investors. In July 2024, K Health secured an equity funding round with Claure Group as a lead investor.
Business overview
K Health provides a data-driven digital primary care platform that leverages artificial intelligence to offer affordable healthcare solutions. Its core technology uses AI to analyze billions of clinical data insights and thousands of doctors' knowledge, helping users understand diagnoses and treatments based on similar symptoms and conditions. The platform serves individuals seeking urgent and primary care, as well as mental health support for anxiety and depression, offering remote treatment plans and prescriptions. K Health operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Digital Medical Diagnostics, targeting patients, providers, and insurance companies.
Strategic signal
K Health continues to attract significant investment, as evidenced by its equity funding round in July 2024 with Claure Group leading. This July 2024 capital infusion signals ongoing investor confidence in K Health's AI-powered digital primary care model and its potential for further expansion in the competitive health tech market.
Log in to access full profile ›Company Intelligence Q&A
- What was K Health's most recent funding activity?
- In July 2024, K Health secured an equity funding round. Claure Group was a lead investor in this round.
- When did K Health acquire Trusst?
- K Health acquired Trusst in August 2021 to expand its comprehensive mental health program.
- What was a significant partnership for K Health in 2022?
- In June 2022, K Health launched its personalized hypertension treatment algorithm, powered by Mayo Clinic Platform Insights.
- When did K Health close its Series E funding round?
- In January 2021, K Health closed its Series E funding round, with Notable Capital as a lead investor.